Jocelyn Zheng

Gastroenterology, immunology and inflammatory disease

1- Therapeutic area deep-dive for pipeline optimization and external BD candidates evaluation in Onco, T2D & Obesity, and Auto-Immune diseases 2- Evaluation of emerging modalities and technology platforms, e.g. AI-driven R&D, neoantigen vaccines, and Radioligand therapy (RLT), and supported the internal incubation of a RLT startup.

In-depth policy analyses of PCG(Protein therapy/ Cell therapy/ Gene therapy) Industry, communicate and cooperate with national and regional regulatory departments and industry associations to support the headquarter innovation strategy planning. Due Diligence of Investment/ BD projects in the PCG field. Support the risk evaluation and operation of in-house PCG projects.

In-house incubation projects investment and operation and completed incubation projects (start-up companies established) in AI-driven drug discovery and neoantigen vaccines. Business development of overseas FIC or BIC medicine and medical devices. Assist in daily operation of Fosunlead platform and incubated start-ups.

Early-stage biotech investment/BD In-house incubation of startups Incubator operation

Zheng Y., Wang L., Sun S., Liu S., Liu M., & Lin J. Phylogenetic and ion-response analyses reveal a relationship between gene expansion and functional divergence in the Ca2+/cation antiporter family in Angiosperms. Plant Mol Biol. 2020 Oct 29. doi: 10.1007/s11103-020-01088-7. Epub ahead of print. PMID: 33123851. Wei, D., Liu, M., Chen, H., Zheng, Y., Liu, Y., Wang, X., Yang, S., Zhou, M., & Lin, J. (2018). INDUCER OF CBF EXPRESSION 1 is a male fertility regulator impacting anther dehydration in Arabidopsis[J]. PLoS Genetics, 14(10): e1007695